You just read:

Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia

News provided by

Rigel Pharmaceuticals, Inc.

May 16, 2019, 07:30 ET